Download PDF
Geburtshilfe Frauenheilkd 2020; 80(07): 672-674
DOI: 10.1055/a-1076-3866
GebFra Magazin
Aktuell diskutiert

Haben orale Kontrazeptiva einen Stellenwert für die Prophylaxe und Therapie der Endometriose?

Karl-Werner Schweppe
,
Andreas D. Ebert
› Further Information
Also available at
    Permissions and Reprints

Trotz guter Erfahrungen in der klinischen Praxis gibt es aktuell auch Zweifel am Nutzen der Anwendung von kombinierten östrogenhaltigen Kontrazeptiva (KOK) bei Dysmenorrhö, wenn diese ein Symptom der Endometriose ist [1].

Publication History

Article published online:
14 July 2020

Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Chapron C, Souza C, Borghese B. et al. Oral contraceptives and endometriosis: phe past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011; 26: 2028-2035
    CrossrefPubMedGoogle Scholar
  • 2 Koga K, Takamura M, Fujii T. et al. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril 2015; 104: 793-801
    CrossrefPubMedGoogle Scholar
  • 3 Vercellini P, Eskenazi B, Consonni D. et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 2011; 17: 159-170
    CrossrefPubMedGoogle Scholar
  • 4 Barbieri RL. Hormone treatment of endometriosis. The estrogen threshold hypothesis. Am J Obstet Gynecol 1992; 166: 740-745
    CrossrefPubMedGoogle Scholar
  • 5 Deb S, Campbell BK, Pincott-Allen C. et al. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound. Ultrasound Obstet Gynecol 2012; 39: 574-580
    CrossrefPubMedGoogle Scholar
  • 6 Dunselman GA, Vermeulen N, Becker C. et al. European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014; 29: 400-412
    CrossrefPubMedGoogle Scholar
  • 7 Brown J, Crawford TJ, Datta S. et al. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2018; (05) CD001019
    PubMedGoogle Scholar
  • 8 Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017; 107: 533-536
    CrossrefPubMedGoogle Scholar
  • 9 Jenkins TR, Liu CY, White J. Does response to hormonal therapy predict presence or absence of endometriosis?. J Minim Invasive Gynecol 2008; 15: 82-86
    CrossrefPubMedGoogle Scholar
  • 10 Harada T, Momoeda M, Taketani Y. et al. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis. A placebo-controlled, double-blind, randomized trial. Fertil Steril 2008; 90: 1583-1588
    CrossrefPubMedGoogle Scholar
  • 11 Tandoi I, Somigliana E, Riparini J. et al. High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol 2011; 24: 376-379
    CrossrefPubMedGoogle Scholar
  • 12 Vercellini P, Somigliana E, Daguati R. et al. Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 2008; 198: 504.e1-504.e5
    CrossrefPubMedGoogle Scholar
  • 13 Nezhat F, Nezhat C, Allan CJ. et al. Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis. J Reprod Med 1992; 37: 771-776
    PubMedGoogle Scholar
  • 14 Herbel J. Untersuchungen zur Expression und endokrinen Regulation der epidermal growth factor receptor Familie in endometriotischen Läsionen [Dissertation]. Berlin: Charité – Universitätsmedizin Berlin; 2007
    PubMedGoogle Scholar